Company Filing History:
Years Active: 1994-1998
Title: Innovations of Hong-Seob Jeon in Antiviral Protein Development
Introduction
Hong-Seob Jeon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antiviral proteins. With a total of five patents to his name, Jeon is recognized for his innovative approaches to combating viral infections.
Latest Patents
Among his latest patents is the discovery of a novel genome coding for the Phytolacca insularis antiviral protein (PIP). This protein was isolated from the plant Phytolacca insularis Nakai. Jeon and his team developed a recombinant vector for the expression of the PIP genome, which has shown a nucleotide homology of about 82% with the genome of the Phytolacca americana antiviral protein. The PIP cDNA consists of 918 base pairs, including one open reading frame and a termination codon. Additionally, a polyadenylation signal, which is common in the mRNA of most plants and animals, is located upstream of 33 base pairs from the polyadenylation site. The recombinant PIP has been proven to inhibit the growth of E. coli HB101 transformed with the expression vector. Another significant patent involves a process for preparing virus-resistant transgenic plants that produce the antiviral protein, utilizing the recombinant vector for PIP expression.
Career Highlights
Hong-Seob Jeon is currently associated with Jin Ro Limited, where he continues to advance his research in antiviral proteins. His work has garnered attention in the scientific community for its potential applications in agriculture and medicine.
Collaborations
Jeon collaborates with notable colleagues, including Man-Keun Kim and Kyu-Whan Choi, who contribute to his research endeavors.
Conclusion
Hong-Seob Jeon's innovative work in the field of antiviral proteins exemplifies the importance of biotechnology in addressing viral challenges. His patents reflect a commitment to scientific advancement and the potential for real-world applications in disease resistance.